Developing broadly enabling chemical sensing technologies based on fluorescence sensing with initial products for implantable glucose sensors and metabolic rate monitors

Sectors
Healthcare
Life Sciences
First Invested
1997
Early
Company Status
IPO/Public
NYSE: SENS